Molecular diagnostics kits
Ended Purchase Order Awarded Last action
- Contract number
- HT001424P0239
- Awardee
-
Biofire Defense LLC UEI NHMDGM122546
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,540,405
Award facts
- Opportunity
-
- HT001424R0029 Solicitation number
- Contract value 44% obligated
-
- $1,540,405.30 Current, with exercised options
- $3,498,082.42 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $652,559 | |
| Other Administrative Action | $0 | |
| Original award | $887,846 |
About this award
The Defense Health Agency (DHA) awarded a $3.5 million firm fixed-price purchase order to Biofire Defense LLC on September 30, 2024, for molecular diagnostic kits with a completion date of September 29, 2029. This contract, which includes no set-aside designation, will be performed in Bethesda, Maryland. Biofire Defense is a specialized manufacturer of biological agent identification and molecular diagnostic solutions based in Salt Lake City, Utah, known for its FilmArray and RAZOR Mk II systems that support biodefense and public health preparedness across federal agencies.
This procurement represents a continuation of DHA's investment in diagnostic capabilities through an established vendor with substantial federal contracting experience. Biofire Defense has demonstrated its competitive positioning across multiple federal agencies, including the Department of Defense, Department of State, and National Institutes of Health, through previous awards covering respiratory panels, gastrointestinal panels, global fever panels, and related testing kits. The company currently maintains significant federal indefinite delivery vehicles, including a $21 million Other Transaction agreement with the Joint Program Executive Office for Chemical and Biological Defense focused on developing reusable diagnostic devices for biological threat and infectious disease detection, which provides additional context for DHA's selection of this vendor to support its diagnostic testing requirements.
Quick answers
Who was awarded contract HT001424P0239?
HT001424P0239 was awarded to Biofire Defense LLC by Defense Health Agency (Department of Defense) on September 30, 2024.
How much is contract HT001424P0239 worth?
The government has obligated $1,540,405 on HT001424P0239. Its potential value, with all options, is $3,498,082.
Was contract HT001424P0239 competed?
The extent of competition for HT001424P0239 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award